Results 201 to 210 of about 287,339 (268)

Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. [PDF]

J Am Heart Assoc
Hogan S, Szarek M, Debus ES, Nehler M, Anand SS, Patel MR, Pap AF, Deng H, Hodge S, Haskell LP, Muehlhofer E, Berkowitz SE, Bauersachs RM, Bonaca MP.   +13 more
europepmc   +1 more source

Differential effect of female gender on coronary artery disease and peripheral artery disease.

, 2002
H.W.O. Roeters van Lennep, H. Tineke Westerveld, A. H. Zwinderman, Jeanine E. Roeters van Lennep, H. Bruins Slot, D.W. Erkelens, E. E. van der Wall   +6 more
openalex   +1 more source

Accuracy of Noncontrast Quiescent-Interval Single-Shot Lower Extremity MR Angiography Versus CT Angiography for Diagnosis of Peripheral Artery Disease

, 2017
Ákos Varga‐Szemes, Julian L. Wichmann, U. Joseph Schoepf, Pál Surányi, Carlo N. De Cecco, Giuseppe Muscogiuri, Damiano Caruso, Ricardo Yamada, Sheldon E. Litwin, Christian Tesche, Taylor M. Duguay, Shivraman Giri, Rozemarijn Vliegenthart, Thomas M. Todoran   +13 more
openalex   +2 more sources

Characterization of inflammatory pseudotumors in a large animal model of liver cancer

Animal Models and Experimental Medicine, EarlyView.
CT images in arterial and portal venous phases of liver lesions in Oncopig. Abstract Background The development of relevant and robust large animal models of hepatocellular carcinoma is needed to test new therapeutic strategies for this disease. Transgenic approaches hold promise in addressing this complex problem. One such model, the Oncopig, has been
Erik N. K. Cressman, Samantha Hicks, Natalie W. Fowlkes, Danielle L. Stolley, Maria Sophia Stenkamp   +4 more
wiley   +1 more source

Long-Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long-Term Survival Study (PEARLS). [PDF]

J Am Heart Assoc
Girotra S, Li Q, Vaughan-Sarrazin M, Lund BC, Al-Garadi M, Beckman JA, Nathani R, Hoffman RM, Chan PS, Banerjee S, Tsai S, Kumbhani DJ, Minniefield-Young N, Smolderen KG, Arya S, Nguyen C, Matheny ME, Gobbel GT.   +17 more
europepmc   +1 more source

MANAGEMENT OF AORITIC AND PERIPHERAL VASCULAR DISEASES WITH CORONARY ARTERY DISEASE

, 1994
Hidetoshi Tsuboi, Haruhiko Okada, K. Nishida, Kazuhiro Suzuki, A Furunaga, Kimikazu Hamano, Yoshihiko Fujimura, Kensuke Esato   +7 more
openalex   +2 more sources

Establishment of a mouse model of TMAO‐induced cardiac injury and application of MICT intervention

Animal Models and Experimental Medicine, EarlyView.
This study aims to explore the establishment of an animal model of cardiac injury induced by trimethylamine‐N‐oxide (TMAO), a metabolite secreted by gut microorganisms, and to investigate its application in moderate‐intensity continuous training (MICT) intervention.
Zhongping Xie, Hong Zou, Lijing Gong, Minghui Lin, Caihua Huang   +4 more
wiley   +1 more source

Unveiling the Sex-Based Divide: Exploring Sex Differences in Peripheral Artery Disease. [PDF]

Curr Atheroscler Rep
Kansul F, Crichton AB, Pomozi E, Roy TL.
europepmc   +1 more source

Back Again to the Future: A New Era for Cerebroprotection

Annals of Neurology, EarlyView.
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley   +1 more source

Gastrocnemius Myofiber Type and Mitochondrial Alterations Associated With Peripheral Artery Disease Severity. [PDF]

Function (Oxf)
Kosmac K, Wang RD, Stewart J, Kaur P, Ismaeel A, Ahsan H, Hartnell L, Dupont-Versteegden EE, McDermott MM, Sufit RL, Ferrucci L, Peterson CA.   +11 more
europepmc   +1 more source